Psilocybin
Bia Labate of the Chacruna Institute: Truffle Talks Episode 14
James sits down with Dr. Bia Labate to discuss the many projects of the Chacruna Institute. Dr. Beatriz Caiuby Labate (Bia Labate) is a queer Brazilian…
James sits down with Dr. Bia Labate to discuss the many projects of the Chacruna Institute.
Dr. Beatriz Caiuby Labate (Bia Labate) is a queer Brazilian anthropologist based in San Francisco.
She has a Ph.D. in social anthropology from the State University of Campinas (UNICAMP), Brazil. Her main areas of interest are the study of plant medicines, drug policy, shamanism, ritual, religion, and social justice.
She is Executive Director of the Chacruna Institute for Psychedelic Plant Medicines. She serves as Public Education and Culture Specialist at the Multidisciplinary Association for Psychedelic Studies (MAPS), and Adjunct Faculty at the East-West Psychology Program at the California Institute of Integral Studies (CIIS).
She is also a member of the Oregon Psilocybin Advisory Board’s Research Subcommittee, and Diversity, Culture, and Ethics Advisor at the Synthesis Institute. Additionally, she is a co-founder of the Interdisciplinary Group for Psychoactive Studies (NEIP) in Brazil and editor of its site. She is author, co-author, and co-editor of twenty-four books, two special-edition journals, and several peer-reviewed articles.
The post Bia Labate of the Chacruna Institute: Truffle Talks Episode 14 appeared first on Truffle Report.
psilocybin psychedelic psychoactive synthesis research-
Law & Regulation1 week ago
Relmada Therapeutics trims losses, slashes research costs
-
Psychedelics1 week ago
Silo Pharma Exercises Option for Exclusive License Agreement for First-in-Class PTSD and Stress-Induced Anxiety Therapeutic
-
Psychedelics1 week ago
Numinus Wellness Submits Clinical Trial Application
-
Psychedelics1 week ago
Elon Musk Continues To Defend Ketamine
-
Psychedelics1 week ago
Psyence Biomedical Ltd. Announces Results of Recent Study Highlighting Benefits of Nature Derived Psilocybin Vs. Synthetic Psilocybin
-
Psychedelics1 week ago
MindBio Therapeutics Corp. Begins Phase 2B Take-Home Microdosing Clinical Trial in Patients with Major Depressive Disorder
-
Psilocybin7 days ago
Indigenous Psilocybin Practices Around the World
-
Psychedelics1 week ago
Cybin to Present at Public Ventures Discovery Day on March 19th in Dallas